Finance

Lists
Why is AGN down 7,14%?
Dive Deeper
AGN:ASX
Argenica Therapeutics Ltd
A$0,13
-7,14%
(-0,010) 1D
2 Okt., 16:00:00 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for AGN...
Open
A$0,13
High
A$0,13
Low
A$0,13
Mkt. cap
16,70 m
Avg. vol.
75,56 k
Volume
87,49 k
52-wk high
A$0,34
52-wk low
A$0,09
EPS
-A$0,01
Shares outstanding
128,46 m
Open
A$0,13
High
A$0,13
Low
A$0,13
Mkt. cap
16,70 m
Avg. vol.
75,56 k
Volume
87,49 k
52-wk high
A$0,34
52-wk low
A$0,09
EPS
-A$0,01
Shares outstanding
128,46 m
News stories
From web sources and news partners
About Argenica Therapeutics Ltd
CEO-
Employees-
Founded2019
Headquarters-
SectorPharmaceutical industry
Websiteargenica.com.au
Last report
24 Jul. 2026
Fiscal period
Q4 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
2,43 m / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
313,37 k
313,37 k
2,43 m
2,43 m
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,52 m
1,52 m
588,41 k
588,41 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
739,40 k
739,40 k
643,55 k
643,55 k
Operating expense
2,27 m
2,27 m
1,26 m
1,26 m
Total operating expenses
2,27 m
2,27 m
1,26 m
1,26 m
Operating income
-1,96 m
-1,96 m
1,17 m
1,17 m
Other non operating income
-
-
-
-
EBT including unusual items
-1,91 m
-1,91 m
1,23 m
1,23 m
EBT excluding unusual items
-1,91 m
-1,91 m
1,23 m
1,23 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
26,46 k
26,46 k
Net income
-1,91 m
-1,91 m
1,23 m
1,23 m
Net profit margin
-609,00%
-609,00%
50,46%
50,46%
Earnings per share
-
-
-
-
Interest and investment income
46,72 k
46,72 k
59,29 k
59,29 k
Interest expense
-94,00
-94,00
-63,00
-63,00
Net interest expenses
46,62 k
46,62 k
59,23 k
59,23 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme